BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9230741)

  • 1. Surfactant composition in infants and young children with cystic fibrosis.
    Hull J; South M; Phelan P; Grimwood K
    Am J Respir Crit Care Med; 1997 Jul; 156(1):161-5. PubMed ID: 9230741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elemental content of airway surface liquid from infants with cystic fibrosis.
    Hull J; Skinner W; Robertson C; Phelan P
    Am J Respir Crit Care Med; 1998 Jan; 157(1):10-4. PubMed ID: 9445271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis.
    Meyer KC; Sharma A; Brown R; Weatherly M; Moya FR; Lewandoski J; Zimmerman JJ
    Chest; 2000 Jul; 118(1):164-74. PubMed ID: 10893374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered phospholipid composition and aggregate structure of lung surfactant is associated with impaired lung function in young children with respiratory infections.
    Mander A; Langton-Hewer S; Bernhard W; Warner JO; Postle AD
    Am J Respir Cell Mol Biol; 2002 Dec; 27(6):714-21. PubMed ID: 12444031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis.
    Noah TL; Murphy PC; Alink JJ; Leigh MW; Hull WM; Stahlman MT; Whitsett JA
    Am J Respir Crit Care Med; 2003 Sep; 168(6):685-91. PubMed ID: 12829455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HGU/m1HGU mice.
    Bernhard W; Wang JY; Tschernig T; Tümmler B; Hedrich HJ; von der Hardt H
    Thorax; 1997 Aug; 52(8):723-30. PubMed ID: 9337833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional heterogeneity of pulmonary surfactant protein-D in cystic fibrosis.
    Kotecha S; Doull I; Davies P; McKenzie Z; Madsen J; Clark HW; McGreal EP
    Biochim Biophys Acta; 2013 Dec; 1832(12):2391-400. PubMed ID: 24120837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower airway inflammation in infants and young children with cystic fibrosis.
    Armstrong DS; Grimwood K; Carlin JB; Carzino R; Gutièrrez JP; Hull J; Olinsky A; Phelan EM; Robertson CF; Phelan PD
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1197-204. PubMed ID: 9351622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.
    Postle AD; Mander A; Reid KB; Wang JY; Wright SM; Moustaki M; Warner JO
    Am J Respir Cell Mol Biol; 1999 Jan; 20(1):90-8. PubMed ID: 9870921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis.
    Griese M; Essl R; Schmidt R; Rietschel E; Ratjen F; Ballmann M; Paul K;
    Am J Respir Crit Care Med; 2004 Nov; 170(9):1000-5. PubMed ID: 15271694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis.
    von Bredow C; Birrer P; Griese M
    Eur Respir J; 2001 Apr; 17(4):716-22. PubMed ID: 11401069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary surfactant in cystic fibrosis.
    Griese M; Birrer P; Demirsoy A
    Eur Respir J; 1997 Sep; 10(9):1983-8. PubMed ID: 9311489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant protein levels in severe respiratory syncytial virus infection.
    Kerr MH; Paton JY
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1115-8. PubMed ID: 10194154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.
    Konstan MW; Hilliard KA; Norvell TM; Berger M
    Am J Respir Crit Care Med; 1994 Aug; 150(2):448-54. PubMed ID: 8049828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis.
    Dakin CJ; Numa AH; Wang H; Morton JR; Vertzyas CC; Henry RL
    Am J Respir Crit Care Med; 2002 Apr; 165(7):904-10. PubMed ID: 11934712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening.
    Armstrong DS; Hook SM; Jamsen KM; Nixon GM; Carzino R; Carlin JB; Robertson CF; Grimwood K
    Pediatr Pulmonol; 2005 Dec; 40(6):500-10. PubMed ID: 16208679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary oxidative stress response in young children with cystic fibrosis.
    Hull J; Vervaart P; Grimwood K; Phelan P
    Thorax; 1997 Jun; 52(6):557-60. PubMed ID: 9227724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway remodelling in children with cystic fibrosis.
    Hilliard TN; Regamey N; Shute JK; Nicholson AG; Alton EW; Bush A; Davies JC
    Thorax; 2007 Dec; 62(12):1074-80. PubMed ID: 17526676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis.
    Kirchner KK; Wagener JS; Khan TZ; Copenhaver SC; Accurso FJ
    Am J Respir Crit Care Med; 1996 Nov; 154(5):1426-9. PubMed ID: 8912759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis.
    Regamey N; Tsartsali L; Hilliard TN; Fuchs O; Tan HL; Zhu J; Qiu YS; Alton EW; Jeffery PK; Bush A; Davies JC
    Thorax; 2012 Feb; 67(2):164-70. PubMed ID: 22008188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.